mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.3 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |